CATALYST PHARMACEUTICALS, INC.: 10-Q filed 2014-05-15
What CATALYST PHARMACEUTICALS, INC. reported in its quarterly report filed 2014-05-15 (fiscal Q1 2014): 24 published measures, 60 facts as tagged in accession 0001193125-14-201244.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-05-15
- Fiscal period
- fiscal Q1 2014
- Accession
- 0001193125-14-201244 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CATALYST PHARMACEUTICALS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 22,229,580 | USD | |
| At 2013-12-31 | 25,369,554 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 4,591,276 | USD | |
| At 2013-12-31 | 3,978,302 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 17,638,304 | USD | |
| At 2013-12-31 | 21,391,252 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 1,072,465 | USD | |
| At 2013-12-31 | 2,215,958 | USD | |
| At 2013-03-31 | 646,045 | USD | |
| At 2012-12-31 | 1,409,939 | USD | |
| At 2002-01-04 | 100,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -3,811,119 | USD | 90 |
| 2002-01-05 to 2014-03-31 | -58,144,718 | USD | 4469 |
| 2013-01-01 to 2013-03-31 | -1,744,289 | USD | 90 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 17,306 | USD | 90 |
| 2002-01-05 to 2014-03-31 | 181,946 | USD | 4469 |
| 2013-01-01 to 2013-03-31 | 9,433 | USD | 90 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | -58,144,718 | USD | |
| At 2013-12-31 | -54,333,599 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 52,649 | USD | |
| At 2013-12-31 | 40,628 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 23,130 | USD | 90 |
| 2002-01-05 to 2014-03-31 | 6,161,185 | USD | 4469 |
| 2013-01-01 to 2013-03-31 | 41,752 | USD | 90 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -3,508,365 | USD | 90 |
| 2002-01-05 to 2014-03-31 | -58,301,661 | USD | 4469 |
| 2013-01-01 to 2013-03-31 | -1,705,430 | USD | 90 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 22,168,043 | USD | |
| At 2013-12-31 | 25,320,038 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 2,436,726 | USD | |
| At 2013-12-31 | 2,139,609 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 932,105 | USD | |
| At 2013-12-31 | 850,789 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 3,508,365 | USD | 90 |
| 2002-01-05 to 2014-03-31 | 58,790,619 | USD | 4469 |
| 2013-01-01 to 2013-03-31 | 1,705,430 | USD | 90 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 2,748,683 | USD | 90 |
| 2002-01-05 to 2014-03-31 | 39,148,762 | USD | 4469 |
| 2013-01-01 to 2013-03-31 | 1,092,301 | USD | 90 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 54,145,633 | shares | |
| At 2013-12-31 | 54,132,937 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 75,728,876 | USD | |
| At 2013-12-31 | 75,670,718 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 144,552 | USD | |
| At 2013-12-31 | 133,074 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 91,903 | USD | |
| At 2013-12-31 | 92,446 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 1,504,621 | USD | |
| At 2013-12-31 | 1,288,820 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 883,293 | USD | |
| At 2013-12-31 | 1,609,442 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 759,682 | USD | 90 |
| 2002-01-05 to 2014-03-31 | 19,641,857 | USD | 4469 |
| 2013-01-01 to 2013-03-31 | 613,129 | USD | 90 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 5,285 | USD | 90 |
| 2002-01-05 to 2014-03-31 | 192,646 | USD | 4469 |
| 2013-01-01 to 2013-03-31 | 5,364 | USD | 90 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 81,316 | USD | 90 |
| 2002-01-05 to 2014-03-31 | 932,105 | USD | 4469 |
| 2013-01-01 to 2013-03-31 | -798,478 | USD | 90 |
Inspect the source
- Entity
- CATALYST PHARMACEUTICALS, INC. / CIK 0001369568
- Captured
- 2026-09-21T17:19:25.463Z
- SEC response SHA-256
7cf76a511a9127dd31ed7d53955bbe348f790d8d7fd354d359e6674e7b2af9c9
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001369568.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))